Amneal Pharmaceuticals, Inc. (AMRX) stock
AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3063% above fair value
$21.12−0.11 (-0.52%)
Close on Nov 17, 2026Market cap $6.74BP/E 43.1Yield –
Amneal Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Amneal Pharmaceuticals's market cap was $7.11B on Nov 11, 2026, against $4.01B a year earlier. Over the last 5 years it ranged from $209.81M to $7.11B, with a median of $1.43B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.11B | +76.2% |
| 2025 | Dec 31, 2025 | $4.03B | +73.9% |
| 2024 | Dec 31, 2024 | $2.32B | +147.3% |
| 2023 | Dec 29, 2023 | $938.07M | +211.9% |
| 2022 | Dec 30, 2022 | $300.79M | -58.3% |
| 2021 | Dec 31, 2021 | $721.23M | +7.9% |
| 2020 | Dec 31, 2020 | $668.21M | +7.9% |
| 2019 | Dec 31, 2019 | $619.19M | -28.3% |
| 2018 | Dec 31, 2018 | $863.67M | – |
See a number that looks wrong?